Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionhistone H3K4me/H3K4me2/H3K4me3 demethylase activity

KDM5C KDM5D

1.73e-056222GO:0034647
GeneOntologyMolecularFunctionhistone H3K4 demethylase activity

KDM5C KDM5D

3.23e-058222GO:0032453
GeneOntologyMolecularFunctionhistone H3 demethylase activity

KDM5C KDM5D

4.30e-0428222GO:0141052
GeneOntologyMolecularFunctionhistone demethylase activity

KDM5C KDM5D

5.28e-0431222GO:0032452
GeneOntologyMolecularFunctionprotein demethylase activity

KDM5C KDM5D

5.63e-0432222GO:0140457
GeneOntologyMolecularFunctiondemethylase activity

KDM5C KDM5D

1.07e-0344222GO:0032451
GeneOntologyMolecularFunction2-oxoglutarate-dependent dioxygenase activity

KDM5C KDM5D

2.31e-0365222GO:0016706
GeneOntologyMolecularFunctionDNA-binding transcription factor activity, RNA polymerase II-specific

SOX17 SHOX2 MAZ ATF5 NOBOX FOXE3

3.45e-031412226GO:0000981
GeneOntologyMolecularFunctiondioxygenase activity

KDM5C KDM5D

5.17e-0398222GO:0051213
GeneOntologyBiologicalProcessendodermal digestive tract morphogenesis

SOX17 FGFR2

6.51e-064222GO:0061031
GeneOntologyBiologicalProcessheart morphogenesis

SOX17 SHOX2 FGFR2 SLIT3 SYNPO2L

1.87e-05321225GO:0003007
GeneOntologyBiologicalProcessdigestive tract morphogenesis

SOX17 SHOX2 FGFR2

3.29e-0559223GO:0048546
GeneOntologyBiologicalProcessolfactory bulb interneuron development

ATF5 SLIT3

5.94e-0511222GO:0021891
GeneOntologyBiologicalProcessneuron development

SHOX2 ACHE ARHGAP32 PRKCI FGFR2 SAMD4B ATF5 SLIT3

8.17e-051463228GO:0048666
GeneOntologyBiologicalProcessbranching morphogenesis of a nerve

SHOX2 FGFR2

1.13e-0415222GO:0048755
GeneOntologyBiologicalProcessnegative regulation of apoptotic process

BCL2L12 PRKCI MAZ FGFR2 ATF5 FKBP8 FOXE3

1.22e-041133227GO:0043066
GeneOntologyBiologicalProcesseye development

ACHE PRKCI FGFR2 FKBP8 FOXE3

1.27e-04480225GO:0001654
GeneOntologyBiologicalProcessvisual system development

ACHE PRKCI FGFR2 FKBP8 FOXE3

1.31e-04483225GO:0150063
GeneOntologyBiologicalProcesssensory system development

ACHE PRKCI FGFR2 FKBP8 FOXE3

1.41e-04491225GO:0048880
GeneOntologyBiologicalProcessnegative regulation of programmed cell death

BCL2L12 PRKCI MAZ FGFR2 ATF5 FKBP8 FOXE3

1.50e-041171227GO:0043069
GeneOntologyBiologicalProcessregulation of neurogenesis

SHOX2 ACHE ARHGAP32 PRKCI ATF5

1.76e-04515225GO:0050767
GeneOntologyBiologicalProcessembryonic digestive tract morphogenesis

SHOX2 FGFR2

2.25e-0421222GO:0048557
GeneOntologyBiologicalProcesspositive regulation of axonogenesis

SHOX2 ACHE ARHGAP32

2.35e-04114223GO:0050772
GeneOntologyBiologicalProcessanimal organ morphogenesis

SOX17 SHOX2 PRKCI FGFR2 SLIT3 SYNPO2L FOXE3

2.47e-041269227GO:0009887
GeneOntologyBiologicalProcessregulation of stem cell proliferation

SOX17 SHOX2 FGFR2

2.66e-04119223GO:0072091
GeneOntologyBiologicalProcessaxonogenesis

SHOX2 ACHE ARHGAP32 FGFR2 SLIT3

2.73e-04566225GO:0007409
GeneOntologyBiologicalProcessolfactory bulb interneuron differentiation

ATF5 SLIT3

3.48e-0426222GO:0021889
GeneOntologyBiologicalProcessregulation of nervous system development

SHOX2 ACHE ARHGAP32 PRKCI ATF5

4.31e-04625225GO:0051960
GeneOntologyBiologicalProcessaxon development

SHOX2 ACHE ARHGAP32 FGFR2 SLIT3

4.88e-04642225GO:0061564
GeneOntologyBiologicalProcesspositive regulation of neurogenesis

SHOX2 ACHE ARHGAP32 PRKCI

4.89e-04354224GO:0050769
GeneOntologyBiologicalProcessdigestive tract development

SOX17 SHOX2 FGFR2

5.45e-04152223GO:0048565
GeneOntologyBiologicalProcessstem cell proliferation

SOX17 SHOX2 FGFR2

5.88e-04156223GO:0072089
GeneOntologyBiologicalProcessembryonic digestive tract development

SHOX2 FGFR2

6.33e-0435222GO:0048566
GeneOntologyBiologicalProcesscardiac chamber morphogenesis

SHOX2 FGFR2 SLIT3

6.45e-04161223GO:0003206
GeneOntologyBiologicalProcesspositive regulation of mesenchymal cell proliferation

SHOX2 FGFR2

6.69e-0436222GO:0002053
GeneOntologyBiologicalProcessdigestive system development

SOX17 SHOX2 FGFR2

7.17e-04167223GO:0055123
GeneOntologyBiologicalProcesssmoothened signaling pathway

SHOX2 FGFR2 FKBP8

8.35e-04176223GO:0007224
GeneOntologyBiologicalProcesssensory organ development

ACHE PRKCI FGFR2 FKBP8 FOXE3

8.74e-04730225GO:0007423
GeneOntologyBiologicalProcesspositive regulation of nervous system development

SHOX2 ACHE ARHGAP32 PRKCI

9.10e-04418224GO:0051962
GeneOntologyBiologicalProcesscell morphogenesis involved in neuron differentiation

SHOX2 ACHE ARHGAP32 FGFR2 SLIT3

9.75e-04748225GO:0048667
GeneOntologyBiologicalProcesscamera-type eye development

ACHE FGFR2 FKBP8 FOXE3

9.77e-04426224GO:0043010
GeneOntologyBiologicalProcesslens fiber cell differentiation

FGFR2 FOXE3

1.00e-0344222GO:0070306
GeneOntologyBiologicalProcessheart development

SOX17 SHOX2 FGFR2 SLIT3 SYNPO2L

1.03e-03757225GO:0007507
GeneOntologyBiologicalProcessneural tube patterning

SOX17 FKBP8

1.05e-0345222GO:0021532
GeneOntologyBiologicalProcessregulation of mesenchymal cell proliferation

SHOX2 FGFR2

1.05e-0345222GO:0010464
GeneOntologyBiologicalProcessregulation of axonogenesis

SHOX2 ACHE ARHGAP32

1.07e-03192223GO:0050770
GeneOntologyBiologicalProcesscell morphogenesis

SOX17 SHOX2 ACHE ARHGAP32 FGFR2 SLIT3

1.24e-031194226GO:0000902
GeneOntologyBiologicalProcessneuron projection morphogenesis

SHOX2 ACHE ARHGAP32 FGFR2 SLIT3

1.33e-03802225GO:0048812
GeneOntologyBiologicalProcesscardiac chamber development

SHOX2 FGFR2 SLIT3

1.43e-03212223GO:0003205
GeneOntologyBiologicalProcessolfactory bulb development

ATF5 SLIT3

1.45e-0353222GO:0021772
GeneOntologyBiologicalProcessplasma membrane bounded cell projection morphogenesis

SHOX2 ACHE ARHGAP32 FGFR2 SLIT3

1.46e-03819225GO:0120039
GeneOntologyBiologicalProcessgrowth

SOX17 ARHGAP32 FGFR2 ATF5 SLIT3 FKBP8

1.48e-031235226GO:0040007
GeneOntologyBiologicalProcesscell projection morphogenesis

SHOX2 ACHE ARHGAP32 FGFR2 SLIT3

1.52e-03826225GO:0048858
GeneOntologyBiologicalProcessolfactory lobe development

ATF5 SLIT3

1.62e-0356222GO:0021988
GeneOntologyBiologicalProcessventricular septum morphogenesis

FGFR2 SLIT3

1.62e-0356222GO:0060412
GeneOntologyBiologicalProcesspositive regulation of cell projection organization

SHOX2 ACHE ARHGAP32 PRKCI

1.69e-03494224GO:0031346
GeneOntologyBiologicalProcessmesenchymal cell proliferation

SHOX2 FGFR2

1.79e-0359222GO:0010463
GeneOntologyBiologicalProcessneuron projection development

SHOX2 ACHE ARHGAP32 PRKCI FGFR2 SLIT3

1.81e-031285226GO:0031175
GeneOntologyBiologicalProcessregulation of morphogenesis of a branching structure

SHOX2 FGFR2

2.17e-0365222GO:0060688
GeneOntologyBiologicalProcessdevelopmental growth

ARHGAP32 FGFR2 ATF5 SLIT3 FKBP8

2.34e-03911225GO:0048589
GeneOntologyBiologicalProcesspositive regulation of stem cell proliferation

SHOX2 FGFR2

2.65e-0372222GO:2000648
GeneOntologyBiologicalProcesspositive regulation of transcription by RNA polymerase II

SOX17 BCL2L12 MAZ FGFR2 ATF5 NOBOX

2.71e-031390226GO:0045944
GeneOntologyBiologicalProcessheart valve development

SHOX2 SLIT3

3.11e-0378222GO:0003170
GeneOntologyBiologicalProcessanimal organ formation

SOX17 FGFR2

3.11e-0378222GO:0048645
GeneOntologyBiologicalProcessreceptor metabolic process

ACHE MVB12A

3.43e-0382222GO:0043112
GeneOntologyBiologicalProcessregulation of neuron projection development

SHOX2 ACHE ARHGAP32 PRKCI

3.67e-03612224GO:0010975
GeneOntologyBiologicalProcesspositive regulation of cell development

SHOX2 ACHE ARHGAP32 PRKCI

3.71e-03614224GO:0010720
GeneOntologyBiologicalProcessdevelopmental growth involved in morphogenesis

ARHGAP32 FGFR2 SLIT3

3.79e-03299223GO:0060560
GeneOntologyBiologicalProcessovarian follicle development

FANCG NOBOX

3.85e-0387222GO:0001541
GeneOntologyCellularComponentchromatin

SOX17 SHOX2 FANCG KDM5C ATF5 KDM5D NOBOX FOXE3

8.06e-051480228GO:0000785
HumanPhenoCorneal perforation

FGFR2 FOXE3

4.85e-06372HP:0100583
DomainLys_sp_deMease-like_dom

KDM5C KDM5D

7.94e-064222IPR013637
DomainPLU-1

KDM5C KDM5D

7.94e-064222PF08429
Domainzf-C5HC2

KDM5C KDM5D

1.32e-055222PF02928
DomainZnf_C5HC2

KDM5C KDM5D

1.32e-055222IPR004198
DomainJmjN

KDM5C KDM5D

5.93e-0510222PF02375
DomainJmjN

KDM5C KDM5D

5.93e-0510222SM00545
DomainJMJN

KDM5C KDM5D

5.93e-0510222PS51183
DomainJmjN

KDM5C KDM5D

5.93e-0510222IPR003349
Domain-

KDM5C KDM5D

1.38e-04152221.10.150.60
DomainARID

KDM5C KDM5D

1.38e-0415222PF01388
DomainBRIGHT

KDM5C KDM5D

1.38e-0415222SM00501
DomainARID_dom

KDM5C KDM5D

1.38e-0415222IPR001606
DomainARID

KDM5C KDM5D

1.38e-0415222PS51011
DomainJmjC

KDM5C KDM5D

3.60e-0424222PF02373
DomainJMJC

KDM5C KDM5D

6.43e-0432222PS51184
DomainJmjC_dom

KDM5C KDM5D

6.43e-0432222IPR003347
DomainJmjC

KDM5C KDM5D

6.84e-0433222SM00558
DomainZinc_finger_PHD-type_CS

KDM5C KDM5D

2.63e-0365222IPR019786
DomainPHD

KDM5C KDM5D

3.49e-0375222PF00628
DomainZnf_PHD-finger

KDM5C KDM5D

3.86e-0379222IPR019787
DomainPHD

KDM5C KDM5D

4.87e-0389222SM00249
DomainZnf_PHD

KDM5C KDM5D

5.09e-0391222IPR001965
DomainZF_PHD_2

KDM5C KDM5D

5.53e-0395222PS50016
DomainZF_PHD_1

KDM5C KDM5D

5.65e-0396222PS01359
Domain-

ACHE ACOT2

8.56e-031192223.40.50.1820
DomainAB_hydrolase

ACHE ACOT2

8.56e-03119222IPR029058
DomainTPR

FANCG FKBP8

9.99e-03129222SM00028
DomainTPR_repeat

FANCG FKBP8

1.06e-02133222IPR019734
Pubmed

Mutations of histone demethylase genes encoded by X and Y chromosomes, Kdm5c and Kdm5d, lead to noncompaction cardiomyopathy in mice.

KDM5C KDM5D

3.82e-07222232081420
Pubmed

Analysis of mutation rates in the SMCY/SMCX genes shows that mammalian evolution is male driven.

KDM5C KDM5D

3.82e-0722229060413
Pubmed

Mouse H-Y encoding Smcy gene and its X chromosomal homolog Smcx.

KDM5C KDM5D

3.82e-07222210441747
Pubmed

Inefficient purifying selection: the mammalian Y chromosome in the rodent genus Mus.

KDM5C KDM5D

3.82e-07222216416087
Pubmed

A mouse Y chromosome gene encoded by a region essential for spermatogenesis and expression of male-specific minor histocompatibility antigens.

KDM5C KDM5D

3.82e-0722227524912
Pubmed

Identification of a mouse male-specific transplantation antigen, H-Y.

KDM5C KDM5D

1.15e-0632227544442
Pubmed

Novel JARID1C/SMCX mutations in patients with X-linked mental retardation.

KDM5C KDM5D

2.29e-06422216541399
Pubmed

X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis.

KDM5C KDM5D

2.29e-06422232732223
Pubmed

A novel X gene with a widely transcribed Y-linked homologue escapes X-inactivation in mouse and human.

KDM5C KDM5D

2.29e-0642227951230
Pubmed

The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases.

KDM5C KDM5D

2.29e-06422217320160
Pubmed

Regional regulation of palatal growth and patterning along the anterior-posterior axis in mice.

SHOX2 FGFR2

2.29e-06422216313398
Pubmed

Cloning and characterization of four murine homeobox genes.

SHOX2 NOBOX

3.82e-0652228855241
Pubmed

Shox2-deficient mice exhibit a rare type of incomplete clefting of the secondary palate.

SHOX2 FGFR2

8.01e-06722216141225
Pubmed

Reduced polyalanine-expanded Arx mutant protein in developing mouse subpallium alters Lmo1 transcriptional regulation.

SHOX2 KDM5C

1.07e-05822224122442
Pubmed

A census of human transcription factors: function, expression and evolution.

SOX17 SHOX2 MAZ ATF5 NOBOX FOXE3

1.62e-0590822619274049
Pubmed

Endoderm-specific deletion of Tbx1 reveals an FGF-independent role for Tbx1 in pharyngeal apparatus morphogenesis.

SOX17 FGFR2

2.09e-051122224812002
Pubmed

PDGF Signaling in Primitive Endoderm Cell Survival Is Mediated by PI3K-mTOR Through p53-Independent Mechanism.

SOX17 FGFR2

2.09e-051122230913328
Pubmed

Fyn and argonaute 2 participate in maternal-mRNA degradation during mouse oocyte maturation.

FGFR2 NOBOX

2.97e-051322235104175
Pubmed

Dynamic patterns of histone H3 lysine 4 methyltransferases and demethylases during mouse preimplantation development.

KDM5C KDM5D

2.97e-051322224619213
Pubmed

Sex differences in structure and expression of the sex chromosome genes CHD1Z and CHD1W in zebra finches.

KDM5C KDM5D

2.97e-051322214660691
Pubmed

A Sprouty4 reporter to monitor FGF/ERK signaling activity in ESCs and mice.

SOX17 FGFR2

2.97e-051322229964027
Pubmed

Distinct Requirements for FGFR1 and FGFR2 in Primitive Endoderm Development and Exit from Pluripotency.

SOX17 FGFR2

3.46e-051422228552557
Pubmed

The Mn1 transcription factor acts upstream of Tbx22 and preferentially regulates posterior palate growth in mice.

SHOX2 FGFR2

3.46e-051422218948418
Pubmed

The septum transversum mesenchyme induces gall bladder development.

SOX17 FGFR2

3.99e-051522223951403
Pubmed

Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome.

KDM5C KDM5D

3.99e-051522214762062
Pubmed

FGF8 Signaling Alters the Osteogenic Cell Fate in the Hard Palate.

SHOX2 FGFR2

5.16e-051722229342370
Pubmed

Fibroblast growth factor receptor signaling is essential for lens fiber cell differentiation.

FGFR2 FOXE3

5.16e-051722218455718
Pubmed

FGFR1 is independently required in both developing mid- and hindbrain for sustained response to isthmic signals.

ACHE FGFR2

5.81e-051822212682014
Pubmed

Sex differences in sex chromosome gene expression in mouse brain.

KDM5C KDM5D

5.81e-051822212023983
Pubmed

Midline radial glia translocation and corpus callosum formation require FGF signaling.

FGFR2 SLIT3

5.81e-051822216715082
Pubmed

Wntless is required for peripheral lung differentiation and pulmonary vascular development.

SOX17 FGFR2

7.21e-052022223523683
Pubmed

The function of FGF signaling in the lens placode.

FGFR2 FOXE3

9.59e-052322221223962
Pubmed

Dlg5 maintains apical aPKC and regulates progenitor differentiation during lung morphogenesis.

PRKCI FGFR2

1.33e-042722223466739
Pubmed

Signaling integration in the rugae growth zone directs sequential SHH signaling center formation during the rostral outgrowth of the palate.

SHOX2 FGFR2

1.43e-042822219782673
Pubmed

Crk proteins transduce FGF signaling to promote lens fiber cell elongation.

FGFR2 FOXE3

1.76e-043122229360039
Pubmed

An atlas of combinatorial transcriptional regulation in mouse and man.

SHOX2 KDM5C ATF5 KDM5D FOXE3

1.86e-0487722520211142
Pubmed

Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM.

KDM5C KDM5D

1.99e-043322226864203
Pubmed

Robo signalling controls pancreatic progenitor identity by regulating Tead transcription factors.

SOX17 SLIT3

2.12e-043422230504829
Pubmed

FGF signaling gradient maintains symmetrical proliferative divisions of midbrain neuronal progenitors.

PRKCI FGFR2

2.24e-043522221074523
Pubmed

WNT/RYK signaling restricts goblet cell differentiation during lung development and repair.

SOX17 PRKCI

3.24e-044222231776260
Pubmed

NANOG initiates epiblast fate through the coordination of pluripotency genes expression.

SOX17 FGFR2

3.89e-044622235729116
Pubmed

Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.

RGL3 ACOT2 MVB12A

4.16e-0423322337704626
Pubmed

Identification of Jmjd3 as an Essential Epigenetic Regulator of Hox Gene Temporal Collinear Activation for Body Axial Patterning in Mice.

KDM5C KDM5D

4.41e-044922234368113
Pubmed

Novel interactive partners of neuroligin 3: new aspects for pathogenesis of autism.

FANCG ACOT2

5.36e-045422225464930
Pubmed

New nomenclature for chromatin-modifying enzymes.

KDM5C KDM5D

5.97e-045722218022353
Cytoband19q13.3

BCL2L12 ATF5

7.11e-048222219q13.3
CytobandEnsembl 112 genes in cytogenetic band chr19p13

RGL3 FKBP8 MVB12A

6.28e-03797223chr19p13
GeneFamilyAT-rich interaction domain containing

KDM5C KDM5D

1.09e-0415192418
GeneFamilyPHD finger proteins|Lysine demethylases

KDM5C KDM5D

2.85e-0424192485
GeneFamilyPHD finger proteins

KDM5C KDM5D

3.97e-039019288
GeneFamilyPRD class homeoboxes and pseudogenes

SHOX2 NOBOX

4.14e-0392192521
CoexpressionGSE16266_CTRL_VS_LPS_STIM_MEF_DN

FANCG MAZ SLIT3 FKBP8

2.16e-05200224M7212
ComputationalPol II transcription.

FANCG KDM5C MAZ

1.76e-0471173MODULE_308
DrugPiperine [94-62-2]; Down 200; 14uM; PC3; HT_HG-U133A

KDM5C FGFR2 ATF5 FKBP8

3.12e-051912244247_DN
DrugFlunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A

ACHE KDM5C MAZ FKBP8

3.18e-051922244303_UP
DrugDentacolor

ARHGAP32 KDM5D

3.20e-059222CID003035662
DrugSimvastatin [79902-63-9]; Down 200; 9.6uM; PC3; HT_HG-U133A

KDM5C MAZ FGFR2 FKBP8

3.31e-051942244244_DN
DrugMetaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; PC3; HT_HG-U133A

MAZ FGFR2 ATF5 FKBP8

3.31e-051942244248_DN
DrugDoxylamine succinate [562-10-7]; Down 200; 10.2uM; PC3; HT_HG-U133A

MAZ FGFR2 ATF5 FKBP8

3.38e-051952244235_DN
DrugSulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A

SHOX2 KDM5C MAZ FKBP8

3.59e-051982244979_DN
DrugTheophylline monohydrate [5967-84-0]; Down 200; 20.2uM; PC3; HT_HG-U133A

KDM5C FGFR2 ATF5 FKBP8

3.66e-051992244228_DN
Drugsilicon carbide

ARHGAP32 KDM5D

5.85e-0512222CID000009863
Drugsoman

ACHE BCL2L12 PRKCI

9.30e-0592223CID000007305
DrugMGA-100

BCL2L12 KDM5D

1.35e-0418222CID000018020
Drugdichloromethanediamine

FANCG BCL2L12 PRKCI ATF5 FKBP8

1.38e-04539225CID005311048
DrugSuper-Bond

ARHGAP32 KDM5D

1.51e-0419222CID000123788
Drugbiperiden

ACHE BCL2L12

2.23e-0423222CID000002381
DrugAZFd

KDM5C KDM5D

2.23e-0423222CID000196489
DrugQ-MS

SHOX2 KDM5D

2.86e-0426222CID000151506
Drugzinc phosphate

ARHGAP32 KDM5D

3.08e-0427222CID000024519
Drugpseudohypericin

PRKCI KDM5D

3.08e-0427222CID005281751
DrugAC1O3R20

ACHE KDM5C

3.32e-0428222CID006335051
Drugmuscarine

ACHE PRKCI MAZ

3.49e-04144223CID000009308
DrugAC1NRAS8

ARHGAP32 SLIT3

4.34e-0432222CID005288068
Drugtrihexyphenidyl

ACHE BCL2L12

4.34e-0432222CID000005572
Druganti-K

ACHE FGFR2

4.62e-0433222CID000005337
DrugTe Al

ARHGAP32 KDM5D

5.20e-0435222CID000168005
DrugiBVE

ARHGAP32 MAZ

5.50e-0436222CID000007992
Drugdigoxigenine

ACHE PRKCI

6.80e-0440222CID000015478
Drugthioflavin

ACHE BCL2L12

6.80e-0440222CID000022251
Drugacrylic acid

ARHGAP32 KDM5D

7.14e-0441222CID000006581
Drugtroglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA

KDM5C FGFR2 FKBP8

7.48e-041872231070_UP
DrugMepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A

KDM5C MAZ FKBP8

7.72e-041892234304_UP
Drug17-AAG; Down 200; 1uM; HL60; HT_HG-U133A

ARHGAP32 FGFR2 ATF5

7.96e-041912232678_DN
Drugwortmannin from Penicillium funiculosum; Down 200; 0.01uM; HL60; HT_HG-U133A

ARHGAP32 ATF5 SYNPO2L

8.08e-041922232703_DN
DrugDeltaline [6836-11-9]; Up 200; 7.8uM; PC3; HT_HG-U133A

MAZ FGFR2 FKBP8

8.20e-041932234306_UP
DrugTrimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; PC3; HT_HG-U133A

KDM5C MAZ FGFR2

8.20e-041932234202_DN
DrugCefalonium [5575-21-3]; Down 200; 8.8uM; PC3; HT_HG-U133A

MAZ FGFR2 FKBP8

8.20e-041932234245_DN
DrugLetrozole [112809-51-5]; Down 200; 14uM; PC3; HT_HG-U133A

KDM5C MAZ FGFR2

8.20e-041932234240_DN
DrugAmprolium hydrochloride [137-88-2]; Down 200; 12.6uM; PC3; HT_HG-U133A

MAZ FGFR2 FKBP8

8.20e-041932234241_DN
DrugIsoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; PC3; HT_HG-U133A

MAZ FGFR2 FKBP8

8.20e-041932234205_DN
DrugMidodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; PC3; HT_HG-U133A

ARHGAP32 KDM5C FKBP8

8.32e-041942232087_DN
DrugFludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A

SHOX2 KDM5C FGFR2

8.32e-041942233977_DN
DrugIndoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A

MAZ FGFR2 ATF5

8.32e-041942234249_DN
DrugClofilium tosylate [92953-10-1]; Down 200; 7.8uM; PC3; HT_HG-U133A

SHOX2 KDM5C FKBP8

8.32e-041942234492_DN
Drug0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A

KDM5C MAZ FKBP8

8.32e-041942234331_DN
DrugIsradipine [75695-93-1]; Down 200; 10.8uM; PC3; HT_HG-U133A

ARHGAP32 KDM5C MAZ

8.32e-041942236347_DN
DrugCephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A

MAZ FGFR2 ATF5

8.32e-041942234242_DN
DrugPhensuximide [86-34-0]; Down 200; 21.2uM; MCF7; HT_HG-U133A

KDM5C ATF5 FKBP8

8.32e-041942233521_DN
DrugIsotretinoin

SOX17 ACOT2 ATF5 SLIT3 FKBP8

8.42e-04799225ctd:D015474
DrugBenfotiamine [22457-89-2]; Up 200; 8.6uM; PC3; HT_HG-U133A

ACHE KDM5C MAZ

8.45e-041952234312_UP
DrugAtovaquone [95233-18-4]; Down 200; 11uM; PC3; HT_HG-U133A

MAZ FGFR2 FKBP8

8.45e-041952234201_DN
DrugIsoniazid [54-85-3]; Down 200; 29.2uM; PC3; HT_HG-U133A

ARHGAP32 KDM5C FGFR2

8.45e-041952235840_DN
DrugChlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A

ARHGAP32 MAZ ATF5

8.45e-041952231700_DN
Drugestradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A

ARHGAP32 FGFR2 SYNPO2L

8.45e-041952232701_DN
DrugGentamicine sulfate [1405-41-0]; Down 200; 2.6uM; MCF7; HT_HG-U133A

SHOX2 KDM5C FKBP8

8.45e-041952232245_DN
DrugSulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A

KDM5C MAZ FKBP8

8.45e-041952234326_DN
DrugPropofol [2078-54-8]; Down 200; 22.4uM; PC3; HT_HG-U133A

SHOX2 FGFR2 FKBP8

8.45e-041952236707_DN
DrugCarbachol [51-83-2]; Up 200; 21.8uM; HL60; HT_HG-U133A

SHOX2 ACHE FGFR2

8.58e-041962233042_UP
Drughaloperidol; Down 200; 10uM; MCF7; HT_HG-U133A

ARHGAP32 FGFR2 FKBP8

8.58e-041962231628_DN
DrugSeneciphylline [480-81-9]; Down 200; 12uM; PC3; HT_HG-U133A

KDM5C MAZ FGFR2

8.58e-041962234238_DN
DrugD-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT_HG-U133A

KDM5C FGFR2 FKBP8

8.58e-041962236782_DN
DrugRapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A

ARHGAP32 FGFR2 ATF5

8.58e-041962232667_DN
DrugN-WB

SOX17 ACHE

8.60e-0445222CID000091419
Drugprocyanidin B2

PRKCI KDM5D

8.60e-0445222CID000122738
DrugFuraltadone hydrochloride [3759-92-0]; Up 200; 11uM; MCF7; HT_HG-U133A

KDM5C FGFR2 FKBP8

8.70e-041972233413_UP
DrugDimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; PC3; HT_HG-U133A

MAZ FGFR2 ATF5

8.70e-041972234207_DN
Drug2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A

KDM5C FGFR2 FKBP8

8.70e-041972235211_DN
Drug17-DMAG; Down 200; 0.1uM; HL60; HT_HG-U133A

MAZ FGFR2 SYNPO2L

8.70e-041972232673_DN
DrugTrichlormethiazide [133-67-5]; Down 200; 10.6uM; HL60; HT_HG-U133A

SHOX2 FGFR2 FKBP8

8.70e-041972232998_DN
DrugCyanocobalamin [68-19-9]; Up 200; 3uM; HL60; HT_HG-U133A

SHOX2 MAZ FKBP8

8.70e-041972231315_UP
DrugPentolinium bitartrate [52-62-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A

SHOX2 KDM5C ATF5

8.70e-041972234699_DN
DrugChlorhexidine [55-56-1]; Up 200; 8uM; PC3; HG-U133A

MAZ FGFR2 SLIT3

8.83e-041982231942_UP
DrugSC 19220; Down 200; 10uM; PC3; HT_HG-U133A

ARHGAP32 KDM5C FKBP8

8.83e-041982237095_DN
Druggenistein; Down 200; 10uM; MCF7; HT_HG-U133A_EA

ARHGAP32 KDM5C FGFR2

8.83e-041982231073_DN
DrugMianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A

ARHGAP32 KDM5C FKBP8

8.83e-041982232068_DN
DrugButylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A

SHOX2 MAZ FKBP8

8.83e-041982236446_DN
DrugMidecamycin [35457-80-8]; Down 200; 5uM; MCF7; HT_HG-U133A

KDM5C MAZ FKBP8

8.83e-041982235345_DN
Drug2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A_EA

KDM5C ATF5 FKBP8

8.83e-041982231020_DN
DrugRoxarsone [121-19-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A

ARHGAP32 KDM5C MAZ

8.83e-041982235470_DN
DrugCanavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A

SHOX2 KDM5C FKBP8

8.83e-041982234782_UP
Drugrosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A

ARHGAP32 FGFR2 SYNPO2L

8.96e-041992232693_DN
DrugIsoxicam [34552-84-6]; Up 200; 12uM; HL60; HT_HG-U133A

FGFR2 ATF5 FKBP8

8.96e-041992231862_UP
DrugDisulfiram [97-77-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A

SHOX2 FGFR2 FKBP8

8.96e-041992232215_DN
Drug(+/-)-blebbistatin; Down 200; 17uM; MCF7; HT_HG-U133A_EA

KDM5C FGFR2 ATF5

8.96e-04199223954_DN
DrugAcenocoumarol [152-72-7]; Down 200; 11.4uM; PC3; HT_HG-U133A

KDM5C MAZ ATF5

8.96e-041992232077_DN
DrugChloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; HL60; HT_HG-U133A

SHOX2 KDM5C FGFR2

8.96e-041992233011_DN
DrugBrompheniramine maleate [980-71-2]; Down 200; 9.2uM; PC3; HT_HG-U133A

MAZ FGFR2 FKBP8

8.96e-041992234013_DN
DrugDiphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A

SHOX2 KDM5C FKBP8

8.96e-041992234765_DN
DrugIohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A

SHOX2 ATF5 FKBP8

9.09e-042002233322_UP
Drugnordihydroguaiaretic acid; Up 200; 1uM; HL60; HT_HG-U133A

SHOX2 FGFR2 FKBP8

9.09e-042002231164_UP
DrugCarteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A

SHOX2 KDM5C FGFR2

9.09e-042002233276_DN
DrugSulfathiazole [72-14-0]; Up 200; 15.6uM; MCF7; HT_HG-U133A

SHOX2 KDM5C FGFR2

9.09e-042002234769_UP
Diseasesyndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology)

KDM5C KDM5D

3.18e-064222DOID:0060809 (implicated_via_orthology)
Diseaseprimary pulmonary hypertension (is_marker_for)

SOX17 FGFR2

1.48e-058222DOID:14557 (is_marker_for)
Diseasesyndromic intellectual disability (implicated_via_orthology)

KDM5C KDM5D

6.33e-0516222DOID:0050888 (implicated_via_orthology)
Diseaseautism spectrum disorder (implicated_via_orthology)

ARHGAP32 KDM5C KDM5D

1.92e-04152223DOID:0060041 (implicated_via_orthology)
DiseaseMalignant Head and Neck Neoplasm

FANCG FGFR2

4.93e-0444222C0278996
Diseasehigh grade glioma (implicated_via_orthology)

PRKCI FGFR2

4.93e-0444222DOID:3070 (implicated_via_orthology)
Diseaseelectrocardiography

SHOX2 ACHE FGFR2 SYNPO2L

5.82e-04530224EFO_0004327
DiseaseHuntington's disease (is_marker_for)

ACHE KDM5C

7.15e-0453222DOID:12858 (is_marker_for)
Diseaseintellectual disability (implicated_via_orthology)

KDM5C KDM5D

1.42e-0375222DOID:1059 (implicated_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
SAFLGIPFAEPPMGP

ACHE

61

P22303
MGRPAGLFPPLCPFL

BCL2L12

1

Q9HB09
FLPPEPGPFPGIVDM

ACOT2

211

P49753
QMEDFFLDAPPLPPP

ATF5

111

Q9Y2D1
LPPPEDSLFMFPCGP

NOBOX

551

O60393
SVFSPDPMPYEPCLP

FGFR2

796

P21802
FPCVPERPGMPCPGE

PRKCI

106

P41743
MEPGCDEFLPPPECP

KDM5D

1

Q9BY66
MFPVFPCTLLAPPFP

MAZ

1

P56270
PSPPGPCMPEVFLEA

FANCG

386

O15287
PCGFPAPLPPTRMME

ARHGAP32

1406

A7KAX9
TACLLGFLLPPMPPP

RGL3

106

Q3MIN7
PLPLGFSPVCDPMDS

MVB12A

81

Q96EY5
FLAAMEPEPAPAPAP

FKBP8

76

Q14318
TAGHPEPCLMFRPPP

SLC22A13

76

Q9Y226
MFCFDEVPPTPGPIA

SYNPO2L

861

Q9H987
DPDPAFFAAPMPGDC

SOX17

231

Q9H6I2
DMDPPAAFSGFPALP

FOXE3

6

Q13461
MFPAPPFGLPLATLA

SHOX2

276

O60902
PQGFSGPFCEHPPPM

SLIT3

1101

O75094
AILMFPPDCPVPGPD

SAMD4B

651

Q5PRF9
MEPGSDDFLPPPECP

KDM5C

1

P41229